MFAP5 in Cancer-associated Fibroblasts Regulates the Progression of the PDAC

Y. Duan,X. Zhang,J. Xu,H. Yang,T. Liang,X. Bai

DOI: https://doi.org/10.1016/j.hpb.2022.05.670

IF: 3.842

2022-01-01

HPB

Abstract:Introduction: Cancer-associated fibroblasts (CAFs) are one of the main components of the tumor microenvironment in pancreatic ductal adenocarcinoma (PDAC), and microfibrillar-associated protein 5 (MFAP5) is significantly highly expressed in CAFs. However, the exact role of MFAP5 in CAFs on progression of PDAC remains unclear. Method: Western blotting and immunohistochemistry were performed to detect protein expression. Besides, cell proliferation and metastasis ability were tested. Moreover, RNA-seq and cytokine microarray were combined for downstream candidates analysis, which were validated by ELISA and flow cytometry. Furthermore, clinical serum and tissue samples were analyzed to determine the prognostic effect of MFAP5. Results: MFAP5 was highly expressed in PDAC compared with matched normal tissues, and knockdown of MFAP5 led to reduced proliferation and metastasis abilities of CAFs and pancreatic cancer cells. Moreover, tumors were significantly smaller when MFAP5 in CAF was knocked down in vivo tumor-bearing mice. In addition, a significant increase of CD8+T cells infiltration was observed via flow cytometry, and decreased tumor proliferation and increased blood vessle formation were detected by IHC staining. Mechanically, knockdown of MFAPF-KD limited the secretion of hyaluronic acid, CXCL-10 and IL-8 from CAF, and AMG487 and Reparixin could partially reverse the tumor-promotion effects on pancreatic cancer cells. Conclusions: MFAP5 in CAF could regulate the extracellular matrix component and immunology microenvironment of PDAC through secretion of hyaluronic acid, CXCL-10 and IL-8. We would further explore the underlying interaction mechanism, with a view to providing a possible thought of microenvironment combined treatment for the clinical treatment of PDAC.